Elif ERGÜVEN KAYA, İrfan GÜNGÖR, Fatma AKGÜN ŞAHİN, Sıdıka Hülya ÇELEBİ, Demet COŞKUN

Therapeutic effects of intralipid and medialipid emulsionsin a rat model of verapamil toxicity

Background/aim: Lipid emulsions are promising as a potential new therapy for severe verapamil overdose. Our purpose is to draw attention to the choice of solution by investigating the efficacy of intralipid 20% or medialipid 20% in verapamil overdose. Materials and methods: Eighteen adult Sprague Dawley rats were randomly divided into three groups: control (saline; Group C), intralipid 20% (Group I), and medialipid 20% (Group M). Rats were anesthetized with ketamine. Blood gas analysis, baseline heart rate (HRb ), and mean arterial pressure (MAPb ) were evaluated. Verapamil at 2.5 mg kg 1 min 1 was infused until the HRband MAPb decreased by 50% and the times to HR0and MAP0were recorded. Treatment solutions of the groups were administered as 12.4 mL kg 1 in 5 min. Results: While HR did not show a difference, MAP showed statistically significant differences among the groups. Intralipid 20% was more efficient than the other two treatments at an early stage; however, as the administration time progressed, medialipid 20% also turned out to be more efficient than the control treatment. Conclusion: Our findings indicate that in a toxicity model of rats produced with verapamil, intralipid 20% and medialipid 20% solutions partially eliminate cardiac-depressant effects and increase the survival rate.

PDF

___

1. Hume JR, Grant AO. Agents used in cardiac arrhythmias. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 12th ed. New York, NY, USA: McGraw-Hill; 2012. pp. 227-250.
2. Weinberg GL, VadeBoncouer T, Ramaraju GA, Garcia-Amora MF, Cwik MJ. Pretreatment or resuscitation with a lipid infusion shifts the dose-response to bupivacaine-induced asystole in rats. Anesthesiology 1998; 88: 1071-1075.
3. Weinberg G, Ripper R, Feinstein DL, Hoffman W. Lipid emulsion infusion rescues dogs from bupivacaine-induced cardiac toxicity. Reg Anesth Pain Med 2003; 28: 198-202.
4. Weinberg GL, Ripper R, Murphy P, Edelman LB, Hoffman W, Strichartz G, Feinstein DL. Lipid infusion accelerates removal of bupivacaine and recovery from bupivacaine toxicity in the isolated rat heart. Reg Anesth Pain Med 2006; 31: 296-303.
5. Chen Y, Xia Y, Lui L, Shi T, Shi K, Wang Q, Chen L, Papadimos TJ, Xu X. Lipid emulsion reverses bupivacaine-induced asystole in isolated rat hearts. Concentration-response and time-response relationships. Anesthesiology 2010; 113: 1320- 1325.
6. Rosenblatt MA, Abel M, Fischer GW, Itzkovich CJ, Eisenkraft JB. Successful use of a 20% lipid emulsion to resuscitate a patient after a presumed bupivacaine-related cardiac arrest. Anesthesiology 2006; 105: 217-218.
7. Shah S, Gopalakrishnan S, Apuya J, Shah S, Martin T. Use of intralipid in an infant with impending cardiovascular collapse due to local anesthetic toxicity. J Anesth 2009; 23: 439-441.
8. Warren JA, Thoma RB, Georgescu A, Shah SJ. Intravenous lipid infusion in the successful resuscitation of local anestheticinduced cardiovascular collapse after supraclavicular brachial plexus block. Anesth Analg 2008; 106: 1575-1580.
9. Neal JM, Mulroy MF, Weinberg GL. American Society of Regional Anesthesia and Pain Medicine Checklist for Managing Local Anesthetic Systemic Toxicity: 2012 version. Reg Anesth Pain Med 2012; 37: 16-18.
10. Tebbutt S, Harvey M, Nicolas T, Cave G. Intralipid prolongs survival in a rat model of verapamil toxicity. Acad Emerg Med 2006; 13: 134-139.
11. Liang CW, Diamond SJ, Daniel SH. Lipid rescue of massive verapamil overdose: a case report. Journal of Medical Case Reports 2011; 5: 399.
12. Perez E, Bania C, Medlej K, Chu J. Determining the optimal dose of intravenous fat emulsion for treatment of severe verapamil toxicity in rodent model. Acad Emerg Med 2008; 15: 1284-1289.
13. Tuncok Y, Apaydın S, Kalkan S, Ateş M, Güven H. The effects of amrinon and glucagon on verapamil induced cardiovascular toxicity in anaesthetized rats. Int J Exp Pathol 1996; 77: 207- 202.
14. Magdalan J. New treatment methods in verapamil poisoning: experimental studies. Pol J Pharmacol 2003; 55: 425-443.
15. Yuan TH, Kerns WP 2nd, Tomaszewski CA, Ford MD, Kline JA. Insulin-glucose as adjunctive therapy for severe calcium channel antagonist poisoning. J Toxicol Clin Toxicol 1999; 37: 463-474.
16. Ozcan MS, Weinberg G. Update on the use of lipid emulsions in local anesthetic systemic toxicity: a focus on differential efficacy and lipid emulsion as part of advanced cardiac life support. Int Anesthesiol Clin 2011; 49: 91-103.
17. French D, Armenian P, Ruan W, Wong A, Drasner K, Olson KR, Wu AHB. Serum verapamil concentrations before and after Intralipid® therapy during treatment of an overdose. Clin Toxicol (Phila) 2011; 49: 340-344.
18. Bania TC, Chu J, Perez E, Sun M, Hahn IH. Hemodynamic effects of intravenous fat emulsion in an animal model of severe verapamil toxicity resuscitated with atropine, calcium, and saline. Acad Emerg Med 2007; 14: 105-111.
19. Jamaty C, Bailey B, Larocque A, Notebaert E, Sanogo K, Chauny JM. Lipid Emulsions in the treatment of acute poisoning: a systematic review of human and animal studies. Clin Toxicol 2010; 48: 1-27.
20. Bach AC, Babayan VK. Medium-chain triglycerides: an update. Am J Clin Nutr 1982; 36: 950-962.
21. Li Z, Xia Y, Dong X, Chen H, Xia F, Wang X, Dong H, Jin Z, Ding X, Papadimos TJ et al. Lipid resuscitation of bupivacaine toxicity: Long-chain triglyceride emulsion provides benefits over long- and medium-chain triglyceride emulsion. Anesthesiology 2011; 115: 1219-1228.
22. Shin I, Hwang IJ, Sohn JT, Chung YK, Lee HK. The comparative hemodynamic effect of lipid emulsions that was infused intravenously and related mechanism in an in vivo rat heart model. Chest 2012; 142: 399A.
23. Haas DA, Harper DG. Ketamine: a review of its pharmacologic properties and use in ambulatory anesthesia. Anesth Prog 1992; 39: 61-68.